Zhongguo shiyan zhenduanxue, 2016 ITP（血小板减少性紫癜）是一种自身免疫性疾病,主要临床表现为出血,如皮肤黏膜、消化道、颅内出血等,近30%的成人ITP为难治性的,慢性难治性ITP的并发症发生率甚至死亡风险极高[1]。金葡菌肺炎多表现以痰、血、胸水培养结果有金黄色葡萄菌生长为主要依据[2]。但本患者临床特点为高热畏寒,咳嗽、咳痰,合并肝功能异常,胸部CT双肺多发散在多个大小不等类圆形空洞及斑片影 ...
张鸿雁, 贾叶, 李东梅
doaj
Zhongguo shiyan zhenduanxue, 2018 1981年Bast等用卵巢囊腺癌的上皮细胞株,通过杂交瘤技术制备了抗卵巢癌上皮细胞单克隆抗体(OC125),以此抗体测得的抗原称为糖类抗原125(CA125)[1]。CA125在卵巢癌、子宫颈及子宫体癌、子宫内膜癌、子宫腺肌症、子宫内膜异位症、盆腔炎等妇科疾病中的临床应用价值已得到医学界的普遍认可。近年来,越来越多的研究显示,CA125在非妇科疾病(含男性所患疾病)中,如在一些肿瘤、肝病、自身免疫病、心脏疾病、炎症、结核性疾病 ...
李正民 +4 more
doaj
Zhongguo shiyan zhenduanxue, 1997 建立了测定钙调素（ＣａＭ）自身抗体（抗ＣａＭ）的间接ＥＬＩＳＡ法，发现全身性红斑狼疮（ＳＬＥ）、类风湿性关节炎（ＲＡ）、甲状腺功能亢进、桥本甲状腺炎（ＨＴ）、慢性活动性乙型肝炎（ＣＡＨ）患者血清抗ＣａＭ水平与检出率均显著高于正常对照及冠心病、风湿热等其他内科疾病患者。在甲亢与ＨＴ患者中，抗ＣａＭ与抗甲状腺球蛋白（抗ＴＧ）、抗甲状腺过氧化物酶（抗ＴＰＯ）抗体不相关，而在ＳＬＥ与ＲＡ患者，抗ＣａＭ与抗核抗体（ＡＮＡ）有同步性。抗ＣａＭ的出现无疾病特异性，可能在自身免疫病患者的免疫功能紊乱中起一定作用。
doaj
[Exploring the Causal Relationship Between Circulating Immune Cells and Autoimmune Hepatitis Through Mendelian Randomization Analysis]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue BanLeng S, Wang K, Shi Y, Deng C.
europepmc +1 more source
[Neonatal-onset multisystem inflammatory disease in a neonate caused by a <i>de novo</i><i>NLRP3</i> variant]. [PDF]
Zhongguo Dang Dai Er Ke Za ZhiGao FH +4 more
europepmc +1 more source
[Change from Sjögren syndrome to Sjögren disease]. [PDF]
Beijing Da Xue Xue Bao Yi Xue BanLiu Y, Shi G.
europepmc +1 more source
[VEXAS syndrome mimicking relapsing polychondritis: A case report]. [PDF]
Beijing Da Xue Xue Bao Yi Xue BanDong Q, He J, Jia Y, Yao H, Zhang X.
europepmc +1 more source
[Frontier advances in chimeric antigen receptor T cells and chimeric antigen receptor regulatory T cells therapies for autoimmune diseases]. [PDF]
Zhonghua Xue Ye Xue Za ZhiPan SA, Shi J.
europepmc +1 more source
[Chinese guideline on the diagnosis and treatment of adult primary immune thrombocytopenia (2025)]. [PDF]
Zhonghua Xue Ye Xue Za ZhiThrombosis and Hemostasis Group +2 more
europepmc +1 more source
[Rheumatoid arthritis combined with IgG4-related disease successfully treated with rituximab: A case report]. [PDF]
Beijing Da Xue Xue Bao Yi Xue BanDing Y, Wang L, Li C, Lu Z, Shi L.
europepmc +1 more source